evidencegaps
Findings

What do systematic reviews say?

Refine by population, intervention, comparison or outcome
More filters
Evidence found and GRADE certainty

3 questions · 3 findings · 1 reviews · Urology

Sort:Best matchNewestHighest certaintyDownload CSV
No studies found 2 · 66.7%GRADE not reported 0 · 0%Very low 1 · 33.3%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Gemcitabine vs BCG

Time to death from any cause · participants with recurrent (1‐course BCG failure) high‐risk non‐muscle invasive bladder cancer (49 men, 31 women)Country: Italy

The review found no eligible studies for this question.

1 finding from 1 review

Gemcitabine vs Normal saline

Overall survival (absolute effect size estimates based on survival rate at 12 months) · patients with non‐muscle invasive bladder cancer

It is very uncertain whether gemcitabine changes time to death from any cause (absolute effect size estimates based… compared with saline (very low certainty).

1 finding from 1 review